$PM 0.57 Developing
- Date
- Jun 30, 2026
- Mentions
- 2
- Unique authors
- 2
- Sector
- biotech
- Stance
- neutral
- On card
- no
Sentiment history
No sentiment history available for $PM yet.
Sentiment
Notable posts
-
neutral 321 eng
HERE IS EVERY STOCK THAT AI OWNS RIGHT NOW Rallies AI gave Grok, ChatGPT, Claude and more $100K in the stock market ... this is what all of their portfolios look like right now ChatGPT - (+59.3% return so far) Google $GOOGL - $38,534 (How much $$$ GPT owns of Google) Credo $CRDO - $36,310 Amphenol $APH - $14,569 Nebius $NBIS - $11,266 Progressive $PGR - $10,038 Visa $V - $9,734 JPMorgan $JPM - $9,345 Cigna $CI - $8,684 Leidos $LDOS - $6,844 Available Cash - $13,926 Grok - (+45.3% return so far) Salesforce $CRM - $25,920 ServiceNow $NOW - $21,818 Micron Technology $MU - $11,276 Available Cash - $86,243 Claude - (+15.6% return so far) Interactive Brokers $IBKR - $12,656 Google $GOOGL - $12,111 Nvidia $NVDA - $11,676 Adobe $ADBE - $10,071 Visa $V - $9,734 Mondelez $MDLZ - $9,331 Meta Platforms $META - $8,861 Arch Capital $ACGL - $8,207 EMCOR $EME - $8,174 Enterprise Products $EPD - $5,666 CVS Health $CVS - $3,348 Available Cash - $15,732 Gemini - (+12.5% return so far) Northrop Grumman $NOC - $25,037 NextEra Energy $NEE - $19,327 Nvidia - $18,436 ASML $ASML - $16,459 Vertex Pharmaceuticals $VRTX - $12,511 Intuitive Surgical $ISRG - $8,420 ServiceNow $NOW - $6,742 United Rentals $URI - $5,338 Available Cash - $192 Deepseek - (-1.4% return so far) Lockheed Martin $LMT - $23,001 Graco $GGG - $17,020 Northrop Grumman $NOC - $8,872 Bristol-Myers $BMY - $8,591 SLB $SLB - $8,561 Exxon Mobil $XOM - $8,263 Zoetis $ZTS - $7,925 Johnson & Johnson $JNJ - $5,847 HCA Healthcare $HCA - $4,941 Abbott Laboratories $ABT - $2,563 Universal Health Services $UHS - $1,604 Broadcom $AVGO - $1,387 Available Cash - $56 Qwen - (-35.6% return so far) Microsoft $MSFT - $8,305 JPMorgan $JPM - $7,476 Coca-Cola $KO - $7,166 Exxon Mobil - $6,761 Merck $MRK - $6,648 Arch Capital - $6,839 Duke Energy $DUK - $6,212 Allstate $ALL - $3,952 Cincinnati Financial $CINF - $3,636 Philip Morris $PM - $3,234 Bristol-Myers - $1,260 Micron - $690 Available Cash - $2,043
view on X → -
neutral 85 eng
FDA is expected to allow Zyn nicotine pouches to be marketed as less harmful to human health than cigarettes, per Axios. $PM, $BTI, $MO, $TPB.
view on X → -
neutral 26 eng
PHILIP MORRIS $PM WINS FDA BACKING TO MARKET ZYN AS LOWER-RISK THAN CIGARETTES The FDA authorized Philip Morris to market its Zyn nicotine pouches with a modified risk claim, allowing the products to be marketed to adult smokers as carrying a lower risk of tobacco-related disease than cigarettes. The clearance covers 20 Zyn products and is good for five years, per the FDA. Zyn, made by PM's Swedish Match subsidiary, was authorized for sale in January 2025 but had not been allowed to be marketed as a safer alternative until now. The FDA's modified risk claim cites a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis. Seeking Alpha is running a sale right now. If you regularly read financial news, market research, or stock analysis, it's worth a look: https://t.co/2gIyFrmkeW
view on X →
Signal history
| Date | Score | Signal | Mentions | Rank |
|---|---|---|---|---|
| 2026-06-07 | 0.36 | Noisy | 1 | — |
| 2026-06-30 | 0.57 | Developing | 2 | — |